Painless Myocardial Ischemia
Conditions
Brief summary
This study aims to investigate the relationship between the concentrations of blood orphanin, norepinephrine and the morbidity of painless myocardial ischemia in patients with diabetes mellitus. Hopefully, the biomarker(s) in the blood of diabetic patients can be found for screening high risk patients in the diabetes sufferers to prevent the painless myocardial ischemia.
Interventions
DIAGNOSTIC_TESTELISA Test
The levels of orphanin and norepinephrine in blood of diabetic patients with painless myocardial ischemia requiring interventional therapy and diabetic patients without interventional therapy were measured.
Sponsors
Second Hospital of Shanxi Medical University
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Subject has diabetes
Exclusion criteria
* History of myocardial ischemia * Symptoms of myocardial ischemia（ECG changes except）
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Blood orphanin content | 24 hours | Blood orphanin levels in painless diabetic patients with myocardial ischemia requiring interventional therapy and diabetic patients without interventional therapy. |
| Blood norepinephrine content | 24 hours | Blood norepinephrine levels in diabetic patients with painless myocardial ischemia requiring interventional therapy and diabetic patients without interventional therapy |
Countries
China
Outcome results
None listed